Max Access Solutions News Today

The Max Foundation (Max), a leading global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients globally today announced Eli Lilly and Company will provide free of charge access to Verzenio® (abemaciclib) for the treatment of HR-positive, HER2-negative ABC for patients in Kenya.

The Max Foundation (Max) today announced that three patients have started treatment for advanced breast cancer in Mozambique through its Max Access Solutions program. Max, a leading global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to cancer patients, is working in collaboration with multiple partners to implement the program

The Max Foundation (Max) has announced that three patients have started treatment for advanced breast cancer in Mozambique through its Max Access Solutions

The Max Foundation to launch its Max Access Solutions program for patients with HR+/HER2- advanced breast cancer in collaboration with leading oncologists in...

Pharmaceutical companies tout their sustainability efforts. They need to walk the walk and make long-term investments in health equity.

Seattle, WA (PRWEB) October 27, 2022 -- The Max Foundation Announces Multi-Stakeholder Collaboration to Improve Outcomes for People Living with Advanced

Low and middle-income countries typically have lower survival rates from cancer due to a lack of treatments, diagnosis, and support services.